Pathways such as CREB signaling in neurons, cAMP-mediated signaling, G-protein coupled receptor (GPCR) signaling, and S100 family signaling, which are all linked to PD pathology, were enhanced in patients with PD but significantly suppressed in HPgV+ patients with PD (43–46). This evidence concerns the gene CREB1 and Parkinson disease.